BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...$1.2 billion in cash at Dec. 31, 2019. $45M series C round for NeoTX Israel-based NeoTX Therapeutics Ltd....
BioCentury | Oct 31, 2016
Company News

Active Biotech, NeoTX Therapeutics deal

...staphylococcal enterotoxin A (SEA) (see BioCentury, May 27, 2013). Active Biotech AB (SSE:ACTI), Lund, Sweden NeoTX Therapeutics Ltd....
Items per page:
1 - 2 of 2
BioCentury | Feb 19, 2020
Finance

Feb. 19 Financial Quick Takes: bluebird's delayed BLA timeline, plus fundings for NeoTx, Scipher and EnClear

...$1.2 billion in cash at Dec. 31, 2019. $45M series C round for NeoTX Israel-based NeoTX Therapeutics Ltd....
BioCentury | Oct 31, 2016
Company News

Active Biotech, NeoTX Therapeutics deal

...staphylococcal enterotoxin A (SEA) (see BioCentury, May 27, 2013). Active Biotech AB (SSE:ACTI), Lund, Sweden NeoTX Therapeutics Ltd....
Items per page:
1 - 2 of 2